
Corporate venture arm of a healthcare provider that backs early-stage healthcare technology companies

Venture capital firm building life science companies that address unmet medical needs

RiverVest Venture Partners is a venture capital firm that builds life science companies aimed at serious medical needs that are not yet met. Its funds have been raised in several rounds, with the site naming Funds I, II and III and a later Fund IV.
Life science companies. News on its site reports that Good Therapeutics agreed to be acquired by Roche, with a spinout called Bonum Therapeutics launched, and that Standard Bariatrics agreed to be acquired by Teleflex. Both announcements from 2022 carry a St. Louis dateline.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about RiverVest Venture Partners.
Similar listings buyers compare against this one.

Corporate venture arm of a healthcare provider that backs early-stage healthcare technology companies

UK EIS and SEIS funds investing in early-stage biotech therapeutics and related AI

Open startup accelerator offering mentoring, events and expert sprints, with access to an investor community

Venture firm investing in early-stage biotechnology and medical device startups

Deeptech venture firm investing in technology, climate and health startups using engineering talent from the CEE region

Global early-stage venture investor focused solely on legal technology companies
Everything here links back to the same verified catalogue. Pick your next stop.